{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:32:28Z","timestamp":1780144348610,"version":"3.54.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12072-025-10812-8","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T22:44:06Z","timestamp":1743806646000},"page":"647-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"19","author":[{"given":"Warunee","family":"Mingpun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Sobanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mantiwee","family":"Nimworapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneerat","family":"Chayanupatkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerapon","family":"Dhippayom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-1771","authenticated-orcid":false,"given":"Piyameth","family":"Dilokthornsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"5","key":"10812_CR1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/apt.17380","volume":"57","author":"SL Gillespie","year":"2023","unstructured":"Gillespie SL, Hanrahan TP, Rockey DC, Majumdar A, Hayes PC. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023;57(5):454\u2013463. https:\/\/doi.org\/10.1111\/apt.17380","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10812_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217\u2013231. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.013","journal-title":"J Hepatol"},{"key":"10812_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jhep.2021.01.002","volume":"75","author":"C Engelmann","year":"2021","unstructured":"Engelmann C, Claria J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75:549\u2013566. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.002","journal-title":"J Hepatol"},{"issue":"5","key":"10812_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","volume":"79","author":"DE Kaplan","year":"2023","unstructured":"Kaplan DE, Ripoll C, Thiele M, et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2023;79(5):1180\u20131211. https:\/\/doi.org\/10.1097\/HEP.0000000000000647","journal-title":"Hepatology"},{"issue":"4","key":"10812_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jhep.2022.05.021","volume":"77","author":"C Villanueva","year":"2022","unstructured":"Villanueva C, Torres F, Sarin SK, et al. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J Hepatol. 2022;77(4):1014\u20131025. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.021","journal-title":"J Hepatol"},{"issue":"10","key":"10812_CR6","doi-asserted-by":"publisher","first-page":"CD011510","DOI":"10.1002\/14651858.CD011510.pub2","volume":"10","author":"AP Zacharias","year":"2018","unstructured":"Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochrane Database Syst Rev. 2018;10(10):CD011510. https:\/\/doi.org\/10.1002\/14651858.CD011510.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10812_CR7","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1097\/MEG.0000000000001442","volume":"31","author":"J Yang","year":"2019","unstructured":"Yang J, Ge K, Chen L, Yang JL. The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective beta-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis. Eur J Gastroenterol Hepatol. 2019;31(12):1518\u20131526. https:\/\/doi.org\/10.1097\/MEG.0000000000001442","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10812_CR8","doi-asserted-by":"publisher","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. Oct 3 2019;10(10):000142. https:\/\/doi.org\/10.1002\/14651858.ED000142","DOI":"10.1002\/14651858.ED000142"},{"key":"10812_CR9","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"7\u20138","key":"10812_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7\u20138):932\u2013944. https:\/\/doi.org\/10.1002\/sim.3767","journal-title":"Stat Med"},{"issue":"2","key":"10812_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80\u201397. https:\/\/doi.org\/10.1002\/jrsm.1037","journal-title":"Res Synth Methods"},{"issue":"4","key":"10812_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, Higgins JPT, Papakonstantinou T, et al. CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17(4): e1003082. https:\/\/doi.org\/10.1371\/journal.pmed.1003082","journal-title":"PLoS Med"},{"issue":"3","key":"10812_CR13","first-page":"596","volume":"15","author":"TA Ansari","year":"2021","unstructured":"Ansari TA, Kadir S, Dahar BA, Baig MA, Amin MJ, Shaikh SA. The Effectiveness of Carvedilol Versus Propranol in Preventing Recurrence of Bleeding in Cirrhotic Patients: A Comparative Study. Pakistan Journal of Medical and Health Sciences. 2021;15(3):596\u2013598","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"issue":"11","key":"10812_CR14","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.cgh.2019.02.021","volume":"17","author":"WC Chen","year":"2019","unstructured":"Chen WC, Hsin IF, Chen PH, et al. Addition of Carvedilol to Gastric Variceal Obturation Does Not Decrease Recurrence of Gastric Variceal Bleeding in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2019;17(11):2356\u20132363. https:\/\/doi.org\/10.1016\/j.cgh.2019.02.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10812_CR15","doi-asserted-by":"publisher","unstructured":"Gupta V, Rawat R, Shalimar, Saraya A. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT. Hepatol Int. Mar 2017;11(2):181\u2013187. https:\/\/doi.org\/10.1007\/s12072-016-9765-y","DOI":"10.1007\/s12072-016-9765-y"},{"issue":"11","key":"10812_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","volume":"27","author":"GH Lo","year":"2012","unstructured":"Lo GH, Chen WC, Wang HM, Yu HC. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding. J Gastroenterol Hepatol. 2012;27(11):1681\u20131687. https:\/\/doi.org\/10.1111\/j.1440-1746.2012.07244.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10812_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MCG.0000000000001219","volume":"54","author":"M Premkumar","year":"2020","unstructured":"Premkumar M, Rangegowda D, Vyas T, et al. Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis. J Clin Gastroenterol. 2020;54(6):561\u2013568. https:\/\/doi.org\/10.1097\/MCG.0000000000001219","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10812_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jceh.2020.08.009","volume":"11","author":"S Sharma","year":"2021","unstructured":"Sharma S, Agarwal S, Gunjan D, et al. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study. J Clin Exp Hepatol May-Jun. 2021;11(3):343\u2013353. https:\/\/doi.org\/10.1016\/j.jceh.2020.08.009","journal-title":"J Clin Exp Hepatol May-Jun"},{"issue":"5","key":"10812_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jhep.2014.06.015","volume":"61","author":"AJ Stanley","year":"2014","unstructured":"Stanley AJ, Dickson S, Hayes PC, et al. Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. J Hepatol. 2014;61(5):1014\u20131019. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.015","journal-title":"J Hepatol"},{"issue":"5","key":"10812_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","volume":"150","author":"JG Abraldes","year":"2016","unstructured":"Abraldes JG, Villanueva C, Aracil C, et al. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology. 2016;150(5):1160\u20131170. https:\/\/doi.org\/10.1053\/j.gastro.2016.01.004","journal-title":"Gastroenterology"},{"issue":"2","key":"10812_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0168-8278(05)80585-9","volume":"19","author":"SK Acharya","year":"1993","unstructured":"Acharya SK, Dasarathy S, Saksena S, Pande JN. A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol. 1993;19(2):291\u2013300. https:\/\/doi.org\/10.1016\/s0168-8278(05)80585-9","journal-title":"J Hepatol"},{"issue":"5","key":"10812_CR22","first-page":"283","volume":"19","author":"I Ahmad","year":"2009","unstructured":"Ahmad I, Khan AA, Alam A, Butt AK, Shafqat F, Sarwar S. Propranolol, isosorbide mononitrate and endoscopic band ligation - alone or in varying combinations for the prevention of esophageal variceal rebleeding. J Coll Physicians Surg Pak. 2009;19(5):283\u2013286","journal-title":"J Coll Physicians Surg Pak"},{"issue":"2","key":"10812_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0168-8278(05)80586-0","volume":"19","author":"A Avgerinos","year":"1993","unstructured":"Avgerinos A, Rekoumis G, Klonis C, et al. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial J Hepatol. 1993;19(2):301\u2013311. https:\/\/doi.org\/10.1016\/s0168-8278(05)80586-0","journal-title":"A randomized controlled trial J Hepatol"},{"issue":"25","key":"10812_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJM198312223092502","volume":"309","author":"AK Burroughs","year":"1983","unstructured":"Burroughs AK, Jenkins WJ, Sherlock S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med. 1983;309(25):1539\u20131542. https:\/\/doi.org\/10.1056\/NEJM198312223092502","journal-title":"N Engl J Med"},{"issue":"1","key":"10812_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.1840160116","volume":"16","author":"S Dasarathy","year":"1992","unstructured":"Dasarathy S, Dwivedi M, Bhargava DK, Sundaram KR, Ramachandran K. A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class B and C) cirrhotic patients. Hepatology. 1992;16(1):89\u201394. https:\/\/doi.org\/10.1002\/hep.1840160116","journal-title":"Hepatology"},{"issue":"3","key":"10812_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/hep.20584","volume":"41","author":"J de la Pena","year":"2005","unstructured":"de la Pena J, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005;41(3):572\u2013578. https:\/\/doi.org\/10.1002\/hep.20584","journal-title":"Hepatology"},{"issue":"2","key":"10812_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1053\/jhep.2002.30418","volume":"35","author":"A Escorsell","year":"2002","unstructured":"Escorsell A, Banares R, Garcia-Pagan JC, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology. 2002;35(2):385\u2013392. https:\/\/doi.org\/10.1053\/jhep.2002.30418","journal-title":"Hepatology"},{"key":"10812_CR28","doi-asserted-by":"publisher","unstructured":"Evrard S, Dumonceau JM, Delhaye M, Golstein P, Deviere J, Le Moine O. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy. Sep 2003;35(9):729\u201335. https:\/\/doi.org\/10.1055\/s-2003-41581","DOI":"10.1055\/s-2003-41581"},{"issue":"2","key":"10812_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/hep.1840070224","volume":"7","author":"WE Fleig","year":"1987","unstructured":"Fleig WE, Stange EF, Hunecke R, et al. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology Mar-Apr. 1987;7(2):355\u2013361. https:\/\/doi.org\/10.1002\/hep.1840070224","journal-title":"Hepatology Mar-Apr"},{"issue":"25","key":"10812_CR30","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garcia-Pagan","year":"2010","unstructured":"Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370\u20132379. https:\/\/doi.org\/10.1056\/NEJMoa0910102","journal-title":"N Engl J Med"},{"issue":"8","key":"10812_CR31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/gut.2008.171207","volume":"58","author":"JC Garcia-Pagan","year":"2009","unstructured":"Garcia-Pagan JC, Villanueva C, Albillos A, et al. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial. Gut. 2009;58(8):1144\u20131150. https:\/\/doi.org\/10.1136\/gut.2008.171207","journal-title":"Gut"},{"issue":"1","key":"10812_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0016-5085(90)91308-s","volume":"98","author":"OJ Garden","year":"1990","unstructured":"Garden OJ, Mills PR, Birnie GG, Murray GD, Carter DC. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial Gastroenterology. 1990;98(1):185\u2013190. https:\/\/doi.org\/10.1016\/0016-5085(90)91308-s","journal-title":"A controlled trial. Gastroenterology."},{"issue":"1","key":"10812_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000199483","volume":"37","author":"A Gatta","year":"1987","unstructured":"Gatta A, Merkel C, Sacerdoti D, et al. Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. Digestion. 1987;37(1):22\u201328. https:\/\/doi.org\/10.1159\/000199483","journal-title":"Digestion"},{"issue":"2","key":"10812_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1053\/gast.2001.26288","volume":"121","author":"J Gonzalez-Abraldes","year":"2001","unstructured":"Gonzalez-Abraldes J, Albillos A, Banares R, et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology. 2001;121(2):382\u2013388. https:\/\/doi.org\/10.1053\/gast.2001.26288","journal-title":"Gastroenterology"},{"issue":"1","key":"10812_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00042737-200601000-00009","volume":"18","author":"B Gonzalez-Suarez","year":"2006","unstructured":"Gonzalez-Suarez B, Guarner C, Villanueva C, et al. Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol. 2006;18(1):49\u201355. https:\/\/doi.org\/10.1097\/00042737-200601000-00009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10812_CR36","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1053\/jhep.2000.8106","volume":"31","author":"J Gournay","year":"2000","unstructured":"Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology. 2000;31(6):1239\u20131245. https:\/\/doi.org\/10.1053\/jhep.2000.8106","journal-title":"Hepatology"},{"issue":"2","key":"10812_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.28318","volume":"63","author":"IL Holster","year":"2016","unstructured":"Holster IL, Tjwa ET, Moelker A, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding. Hepatology. 2016;63(2):581\u2013589. https:\/\/doi.org\/10.1002\/hep.28318","journal-title":"Hepatology"},{"issue":"5","key":"10812_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jhep.2011.12.021","volume":"56","author":"HH Hung","year":"2012","unstructured":"Hung HH, Chang CJ, Hou MC, et al. Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol. 2012;56(5):1025\u20131032. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.021","journal-title":"J Hepatol"},{"issue":"4","key":"10812_CR39","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/hep.1840160410","volume":"16","author":"O Ink","year":"1992","unstructured":"Ink O, Martin T, Poynard T, et al. Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial. Hepatology. 1992;16(4):912\u2013919. https:\/\/doi.org\/10.1002\/hep.1840160410","journal-title":"Hepatology"},{"issue":"4","key":"10812_CR40","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/00365529009095498","volume":"25","author":"LS Jensen","year":"1990","unstructured":"Jensen LS, Krarup N. Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. Scand J Gastroenterol. 1990;25(4):352\u2013356. https:\/\/doi.org\/10.3109\/00365529009095498","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10812_CR41","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1053\/j.gastro.2009.05.049","volume":"137","author":"A Kumar","year":"2009","unstructured":"Kumar A, Jha SK, Sharma P, et al. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology. 2009;137(3):892\u2013901. https:\/\/doi.org\/10.1053\/j.gastro.2009.05.049","journal-title":"Gastroenterology"},{"issue":"8226","key":"10812_CR42","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/s0140-6736(81)91617-2","volume":"1","author":"D Lebrec","year":"1981","unstructured":"Lebrec D, Nouel O, Bernuau J, Bouygues M, Rueff B, Benhamou JP. Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet. 1981;1(8226):920\u2013921. https:\/\/doi.org\/10.1016\/s0140-6736(81)91617-2","journal-title":"Lancet"},{"issue":"3","key":"10812_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/hep.1840040301","volume":"4","author":"D Lebrec","year":"1984","unstructured":"Lebrec D, Poynard T, Bernuau J, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology May-Jun. 1984;4(3):355\u2013358. https:\/\/doi.org\/10.1002\/hep.1840040301","journal-title":"Hepatology May-Jun"},{"issue":"6","key":"10812_CR44","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1440-1746.2009.05792.x","volume":"24","author":"GH Lo","year":"2009","unstructured":"Lo GH, Chen WC, Chan HH, et al. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol. 2009;24(6):982\u2013987. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05792.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10812_CR45","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/gast.2002.35351","volume":"123","author":"GH Lo","year":"2002","unstructured":"Lo GH, Chen WC, Chen MH, et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology. 2002;123(3):728\u2013734. https:\/\/doi.org\/10.1053\/gast.2002.35351","journal-title":"Gastroenterology"},{"issue":"2","key":"10812_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/hep.22358","volume":"48","author":"GH Lo","year":"2008","unstructured":"Lo GH, Chen WC, Lin CK, et al. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology. 2008;48(2):580\u2013587. https:\/\/doi.org\/10.1002\/hep.22358","journal-title":"Hepatology"},{"issue":"3","key":"10812_CR47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/jhep.2000.16236","volume":"32","author":"GH Lo","year":"2000","unstructured":"Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000;32(3):461\u2013465. https:\/\/doi.org\/10.1053\/jhep.2000.16236","journal-title":"Hepatology"},{"issue":"6","key":"10812_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1067\/mge.2001.114062","volume":"53","author":"GH Lo","year":"2001","unstructured":"Lo GH, Lai KH, Cheng JS, et al. The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. Gastrointest Endosc. 2001;53(6):579\u2013584. https:\/\/doi.org\/10.1067\/mge.2001.114062","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10812_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1440-1746.1993.tb01528.x","volume":"8","author":"GH Lo","year":"1993","unstructured":"Lo GH, Lai KH, Lee SD, Tsai YT, Lo KJ. Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study. J Gastroenterol Hepatol Jul-Aug. 1993;8(4):358\u2013362. https:\/\/doi.org\/10.1111\/j.1440-1746.1993.tb01528.x","journal-title":"J Gastroenterol Hepatol Jul-Aug"},{"issue":"1","key":"10812_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1148\/radiol.15141252","volume":"276","author":"X Luo","year":"2015","unstructured":"Luo X, Wang Z, Tsauo J, Zhou B, Zhang H, Li X. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding. Radiology. 2015;276(1):286\u2013293. https:\/\/doi.org\/10.1148\/radiol.15141252","journal-title":"Radiology"},{"issue":"12","key":"10812_CR51","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","volume":"67","author":"Y Lv","year":"2018","unstructured":"Lv Y, Qi X, He C, et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018;67(12):2156\u20132168. https:\/\/doi.org\/10.1136\/gutjnl-2017-314634","journal-title":"Gut"},{"issue":"8","key":"10812_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","volume":"4","author":"Y Lv","year":"2019","unstructured":"Lv Y, Yang Z, Liu L, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4(8):587\u2013598. https:\/\/doi.org\/10.1016\/S2468-1253(19)30090-1","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10812_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/00365528809093881","volume":"23","author":"UA Marbet","year":"1988","unstructured":"Marbet UA, Straumann A, Gyr KE, et al. Reduction in early recurrence of variceal bleeding by propranolol. Scand J Gastroenterol. 1988;23(3):369\u2013374. https:\/\/doi.org\/10.3109\/00365528809093881","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10812_CR54","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/gut.2009.192039","volume":"59","author":"SR Mishra","year":"2010","unstructured":"Mishra SR, Chander Sharma B, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut. 2010;59(6):729\u2013735. https:\/\/doi.org\/10.1136\/gut.2009.192039","journal-title":"Gut"},{"issue":"6","key":"10812_CR55","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/hep.1840200620","volume":"20","author":"RM Morillas","year":"1994","unstructured":"Morillas RM, Planas R, Cabre E, et al. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects. Hepatology. 1994;20(6):1502\u20131508. https:\/\/doi.org\/10.1002\/hep.1840200620","journal-title":"Hepatology"},{"issue":"2","key":"10812_CR56","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/00000658-200008000-00011","volume":"232","author":"H Orozco","year":"2000","unstructured":"Orozco H, Mercado MA, Chan C, Guillen-Navarro E, Lopez-Martinez LM. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy, and surgery: a prospective, controlled, and randomized trial during 10 years. Ann Surg. 2000;232(2):216\u2013219. https:\/\/doi.org\/10.1097\/00000658-200008000-00011","journal-title":"Ann Surg"},{"issue":"4","key":"10812_CR57","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1053\/gast.2002.35955","volume":"123","author":"D Patch","year":"2002","unstructured":"Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology. 2002;123(4):1013\u20131019. https:\/\/doi.org\/10.1053\/gast.2002.35955","journal-title":"Gastroenterology"},{"issue":"8755","key":"10812_CR58","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/0140-6736(91)93125-s","volume":"337","author":"RM Perez-Ayuso","year":"1991","unstructured":"Perez-Ayuso RM, Pique JM, Bosch J, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991;337(8755):1431\u20131434. https:\/\/doi.org\/10.1016\/0140-6736(91)93125-s","journal-title":"Lancet"},{"issue":"4","key":"10812_CR59","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2036.2006.03007.x","volume":"24","author":"G Romero","year":"2006","unstructured":"Romero G, Kravetz D, Argonz J, et al. Comparative study between nadolol and 5-isosorbide mononitrate vs endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther. 2006;24(4):601\u2013611. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03007.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10812_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0168-8278(91)90828-y","volume":"12","author":"V Rossi","year":"1991","unstructured":"Rossi V, Cales P, Burtin P, et al. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. J Hepatol. 1991;12(3):283\u2013289. https:\/\/doi.org\/10.1016\/0168-8278(91)90828-y","journal-title":"J Hepatol"},{"issue":"9058","key":"10812_CR61","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/s0140-6736(96)08189-5","volume":"349","author":"M Rossle","year":"1997","unstructured":"Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997;349(9058):1043\u20131049. https:\/\/doi.org\/10.1016\/s0140-6736(96)08189-5","journal-title":"Lancet"},{"issue":"9","key":"10812_CR62","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1055\/s-2002-33565","volume":"34","author":"P Sauer","year":"2002","unstructured":"Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy. 2002;34(9):690\u2013697. https:\/\/doi.org\/10.1055\/s-2002-33565","journal-title":"Endoscopy"},{"issue":"5","key":"10812_CR63","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1053\/gast.1997.v113.pm9352865","volume":"113","author":"P Sauer","year":"1997","unstructured":"Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology. 1997;113(5):1623\u20131631. https:\/\/doi.org\/10.1053\/gast.1997.v113.pm9352865","journal-title":"Gastroenterology"},{"issue":"3","key":"10812_CR64","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","volume":"149","author":"T Sauerbruch","year":"2015","unstructured":"Sauerbruch T, Mengel M, Dollinger M, et al. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. Gastroenterology. 2015;149(3):660\u2013668. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.011","journal-title":"Gastroenterology"},{"issue":"5","key":"10812_CR65","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/0016-5085(93)90158-9","volume":"105","author":"J Teres","year":"1993","unstructured":"Teres J, Bosch J, Bordas JM, et al. Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. Gastroenterology. 1993;105(5):1508\u20131514. https:\/\/doi.org\/10.1016\/0016-5085(93)90158-9","journal-title":"Gastroenterology"},{"issue":"3","key":"10812_CR66","first-page":"195","volume":"15","author":"M Urbistondo","year":"1996","unstructured":"Urbistondo M, Torres EA, Castro F, et al. Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study. P R Health Sci J. 1996;15(3):195\u2013199","journal-title":"P R Health Sci J"},{"issue":"25","key":"10812_CR67","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1056\/NEJM199606203342502","volume":"334","author":"C Villanueva","year":"1996","unstructured":"Villanueva C, Balanzo J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996;334(25):1624\u20131629. https:\/\/doi.org\/10.1056\/NEJM199606203342502","journal-title":"N Engl J Med"},{"issue":"9","key":"10812_CR68","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1056\/NEJMoa003223","volume":"345","author":"C Villanueva","year":"2001","unstructured":"Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001;345(9):647\u2013655. https:\/\/doi.org\/10.1056\/NEJMoa003223","journal-title":"N Engl J Med"},{"issue":"5","key":"10812_CR69","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/0016-5085(92)91740-u","volume":"102","author":"JP Vinel","year":"1992","unstructured":"Vinel JP, Lamouliatte H, Cales P, et al. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology. 1992;102(5):1760\u20131763. https:\/\/doi.org\/10.1016\/0016-5085(92)91740-u","journal-title":"Gastroenterology"},{"issue":"2","key":"10812_CR70","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.223201","volume":"308","author":"X Wang","year":"2023","unstructured":"Wang X, Liu G, Wu J, et al. Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis. Radiology. 2023;308(2): e223201. https:\/\/doi.org\/10.1148\/radiol.223201","journal-title":"Radiology"},{"issue":"4","key":"10812_CR71","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/hep.1840060422","volume":"6","author":"D Westaby","year":"1986","unstructured":"Westaby D, Melia W, Hegarty J, Gimson AE, Stellon AJ, Williams R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology Jul-Aug. 1986;6(4):673\u2013675. https:\/\/doi.org\/10.1002\/hep.1840060422","journal-title":"Hepatology Jul-Aug"},{"issue":"3","key":"10812_CR72","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/hep.1840110304","volume":"11","author":"D Westaby","year":"1990","unstructured":"Westaby D, Polson RJ, Gimson AE, Hayes PC, Hayllar K, Williams R. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Hepatology. 1990;11(3):353\u2013359. https:\/\/doi.org\/10.1002\/hep.1840110304","journal-title":"Hepatology"},{"issue":"3","key":"10812_CR73","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","volume":"79","author":"H Larrue","year":"2023","unstructured":"Larrue H, D\u2019Amico G, Olivas P, et al. TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis. J Hepatol. 2023;79(3):692\u2013703. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.028","journal-title":"J Hepatol"},{"issue":"3","key":"10812_CR74","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jgh.15194","volume":"36","author":"A Khan","year":"2021","unstructured":"Khan A, Maheshwari S, Gupta K, Naseem K, Chowdry M, Singh S. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement. J Gastroenterol Hepatol. 2021;36(3):775\u2013781. https:\/\/doi.org\/10.1111\/jgh.15194","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10812_CR75","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1053\/jhep.2003.50133","volume":"37","author":"JG Abraldes","year":"2003","unstructured":"Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003;37(4):902\u2013908. https:\/\/doi.org\/10.1053\/jhep.2003.50133","journal-title":"Hepatology"},{"issue":"2","key":"10812_CR76","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","volume":"18","author":"L Turco","year":"2020","unstructured":"Turco L, Villanueva C, La Mura V, et al. Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis. Clin Gastroenterol Hepatol. 2020;18(2):313\u2013327. https:\/\/doi.org\/10.1016\/j.cgh.2019.05.050","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10812_CR77","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/apt.12721","volume":"39","author":"G D'Amico","year":"2014","unstructured":"D\u2019Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180\u20131193. https:\/\/doi.org\/10.1111\/apt.12721","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10812-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10812-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:29:15Z","timestamp":1749054555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10812-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10812"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10812-8","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}